Form 4: Agilon Health CFO Jeffrey Schwaneke Reports Significant Acquisition and Disposal of Shares
SEC Form 4 Filing
Chief Financial Officer of Agilon Health, Jeffrey A. Schwaneke, reports a series of transactions involving common stock and stock options, resulting in a net increase in his beneficial ownership.
Summary
- Jeffrey A. Schwaneke, the CFO of Agilon Health, filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
- On July 1, 2024, Schwaneke acquired 377,074 shares of common stock, 131,976 restricted stock units, and 150,830 performance stock units, all at a price of $0.
- He also acquired 239,072 options with an exercise price of $6.07, exercisable in four equal installments starting July 1, 2024.
- Following these transactions, Schwaneke beneficially owns 723,930 shares of common stock (including restricted stock units) and 239,072 options.
- The reported transactions include acquisitions of restricted stock units that vest over three or four years and performance stock units that vest based on the company's stock price performance.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing detailing insider transactions. The acquisitions could be seen as a positive signal, but it's not definitive.
Positives
- The acquisition of shares and options by the CFO could be interpreted as a sign of confidence in the company's future performance.
- The vesting schedules for restricted stock units and options provide incentives for long-term commitment from the CFO.
- The performance-based vesting of stock units aligns the CFO's interests with the company's stock price appreciation.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, and restricted stock units to align management's interests with those of shareholders.
- Vesting schedules for equity awards are common and typically range from three to five years.
- Performance-based equity awards are also common, with vesting contingent on achieving specific financial or operational targets.
Stakeholder Impact
- Shareholders may view the CFO's increased ownership as a positive sign of confidence in the company's future.
- Employees may be motivated by the alignment of management's interests with the company's success.
Key Dates
| Date | Description |
|---|---|
| 07/01/2024 | Date of earliest transaction: acquisition of common stock, restricted stock units, performance stock units, and stock options. |
| 07/01/2024 | Vesting start date for restricted stock units and stock options. |
| 07/03/2024 | Date of signature for the Form 4 filing. |
| 07/01/2034 | Expiration date for the acquired options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.